No Data
Ocugen's (OCGN) Stock Surges 195% on Promising Gene Therapy Treatment
Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to Speak During U.S.-India Initiative on Critical and Emerging Technology Workshop
Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit
Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
Sector Update: Health Care Stocks Steady Premarket Wednesday
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Wednesday Ahead of Nvidia Earnings
I Am 102927471 :